Cellulitis and necrotizing fasciitis: Microbiology and pathogenesis;Dermo-hypodermites nécrosantes : Données microbiologiques et pathogéniques

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 3 II, 2001, Pages 382-389

  Bouvet, A ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BACTERIAL TOXIN; CLINDAMYCIN; EXOTOXIN; M PROTEIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROTEIN A; PROTEIN SYNTHESIS INHIBITOR; PYROGEN; STAPHYLOCOCCUS TOXIN; STAPHYLOCOCCUS TOXIN A; STAPHYLOCOCCUS TOXIN C; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BACTEREMIA; BACTERIUM ADHERENCE; BACTEROIDES FRAGILIS; CELLULITIS; CONFERENCE PAPER; DEBRIDEMENT; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; HUMAN; MICROBIOLOGICAL EXAMINATION; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; PATHOGENESIS; PEPTOSTREPTOCOCCUS; PREVOTELLA; SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; TISSUE INJURY; TISSUE NECROSIS; TOXIC SHOCK SYNDROME;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; FASCIITIS, NECROTIZING; HUMANS;

EID: 0035048596     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes
2. Clinical and microbiological features of necrotizing fasciitis
3. Streptococcal toxic shock syndrome from a puncture wound to the foot
4. Streptococcal toxic-shock syndrome : Spectrum of disease, pathogenesis, and new concepts in treatment
5. Érysipèle, cellulites et autres infections cutanées sévères à Streptococcus pyogenes
6. Streptococcal infections of skin and soft tissues
7. Group A streptococcal necrotizing faciitis complicating primary varicella: A series of fourteen patients
8. Musculoskeletal complications of varicella
9. Changing bacteriology of periorbital cellulitis
10. Monomicrobial necrotizing fasciitis complicating pregnancy and puerperium
11. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection
12. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever or uncomplicated pharyngitis
13. Streptococcal M protein : Molecular design and biological behavior
14. Emm typing and validation of provisional M types for group A streptococci
15. M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue
16. Coregulation of type 12 M-protein and streptococcal C5a peptidase genes in group A streptococci : Evidence for a virulence regulon controlled by the virR locus
17. Horizontal gene transfer among group A streptococci : Implications for pathogenesis and epidemiology
18. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections
19. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs
20. Invasive and noninvasive group A streptococcal isolates with different speA alleles in the Netherlands : Genetic relatedness and production of pyrogenic exotoxins A and B
21. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
22. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci and lipopolysaccharide
23. Group A Streptococcus invasive infections : A review
24. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C
25. 3 clones of group A Streptococcus among family members and health care workers
26. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings
27. Aspects of pathogenesis of serious group A streptococcal infections in Sweden 1988-1989
28. Invasive group A Streptococcus infections
29. Group A streptococcal infections in France. Clinical features and epidemiological markers
30. Restricted association between biotypes and serotypes within group A streptococci
31. Septiceamia caused by phenotypic variants of group A streptococci
32. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
33. Comparison of invasive (septicemic) and non invasive strains of group A streptococci isolated during a one-year national survey in France
34. Group A Streptococcus carriage among close contacts of patients with invasive infections
35. Invasive group A streptococal infections
36. Necrotizing fasciitis
37. Nonmemstrual toxic shock syndrome
38. Toxic-shock syndrome associated with phage group-1 staphylococci
39. Actualités sur les toxines de Staphylococcus aureus
40. The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis
41. Mechanisms of microbial synergy in polymicrobial infections
42. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice
43. Activité du di-acétate de midécamycine sur Streptococcus pyogenes comparée à celle des autres macrolides et à celle de la clindamycine. 95/P1
44. E. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients
45. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci
46. Bacterial résistance to antimicrobial agents : Selected problems in France, 1996 to 1998
47. Sensibilité des anaérobies stricts aux antibiotiques : Bilan de l'étude multicentrique 1997-1998 de l'anaéro-club
48. Activity of telithromycin (HM R 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology
49. In vitro activity of HMR 3647 against anaerobic bacteria
50. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorpho-nuclear cells
51. In vitro activities of linezolid against important Gram-positive bacterial pathogens including vancomycin-resistant enterococci
52. The Eagle effect revisited : Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis
53. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin
54. Antibiotic effects on bacterial viability, toxin production, and host response
55. Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes
56. Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Stophylococcus aureus
57. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome
58. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and need for debridements